Carl Domino’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-9,000
| Closed | -$509K | – | 145 |
|
|
2015
Q4 | $509K | Hold |
9,000
| – | – | 0.4% | 68 |
|
|
2015
Q3 | $358K | Hold |
9,000
| – | – | 0.29% | 75 |
|
|
2015
Q2 | $430K | Hold |
9,000
| – | – | 0.29% | 75 |
|
|
2015
Q1 | $357K | Sell |
9,000
-2,000
| -18% | -$79.3K | 0.27% | 83 |
|
|
2014
Q4 | $246K | Sell |
11,000
-4,000
| -27% | -$89.5K | 0.13% | 134 |
|
|
2014
Q3 | $235K | Hold |
15,000
| – | – | 0.13% | 138 |
|
|
2014
Q2 | $223K | Buy |
15,000
+4,000
| +36% | +$59.5K | 0.11% | 153 |
|
|
2014
Q1 | $177K | Sell |
11,000
-3,200
| -23% | -$51.5K | 0.09% | 162 |
|
|
2013
Q4 | $133K | Hold |
14,200
| – | – | 0.07% | 164 |
|
|
2013
Q3 | $161K | Sell |
14,200
-2,500
| -15% | -$28.3K | 0.09% | 153 |
|
|
2013
Q2 | $223K | Buy |
+16,700
| New | +$223K | 0.13% | 127 |
|